Safe cancer care during COVID restrictions

The Victorian Comprehensive Cancer Centre (VCCC) have published a short video clip with a message from Victorian cancer health professionals for patients with cancer and people with signs or symptoms that it is safe to visit GPs and specialists, that being:

"Cancer care continues in our hospitals and clinics. If you have signs or symptoms of cancer, see your GP and attend screening."

Please share: https://youtu.be/zj6CdwkpKPo
Follow VCCC on Twitter: @VicCompCancerCr

In the media: the unfortunate synergy of diabetes and COVID

Coronavirus drawing. Image: USA Today

Professor Paul Zimmet, Professor of Diabetes, Monash University, Australia, and a former advisor at WHO, says between 30-40 per cent of deaths from studies in intensive care units from different countries are people with diabetes. See full article, 'Diabetes is dynamite for person[s] with Covid' published 1 July 2020.

See also a fact check article quoting Paul Zimmet on evidence for COVID-19 acting as a trigger for new onset diabetes: https://www.usatoday.com/story/news/factcheck/2020/06/27/fact-check-doctors-study-whether-covid-19-triggers-diabetes/3267863001/

The website for the newly established COVIDIAB Registry is http://covidiab.e-dendrite.com/

Faculty 3MT Week starts now: 3-10 July - voting closes 11 am Fri 10 July

Faculty 3MT Week is on! Friday 3 July - 11am Friday 10 July. Please watch and vote for your favourite!

Our people's choice (of course) is Alex Dimitropoulos, in Central Clinical School's Department of Diabetes, with her topic, "A spoon full of GLO makes the years go down". What's not to like about that?
See:

• Alex's video
• All videos sites.google.com/monash.edu/mnhsgrresources/3mt
• People's vote link

CCS wins $9M of MRFF Neurological Disorders grants

L-R: Prof Terry O'Brien, Dr Mastura Monif,
Prof Tomas Corcoran (UWA/SPHPM) and Professor Paul Myles

Congratulations to Central Clinical School researchers, Professor Terry O'Brien, Dr Mastura Monif and Professor Paul Myles, who jointly with School of Public Health and Preventive Medicine researcher Professor Tomas Corcoran have won approximately $9M of grants under the 2019 MRFF RCRDUN Neurological Disorders Mission 2020. The initiative had a total of $21.8M on offer nationwide as announced by Minister for Health Greg Hunt on 25 June 2020. See detail below.

Trial to help people with Motor Neurone Disease breathe easier at night receives MRFF funding

Professor Natasha Lannin

A $35.9M boost for rare cancers, rare diseases and unmet medical needs (RCRDUN) was announced 24 June by the Minister for Health, Greg Hunt for the Medical Research Future Fund RCRDUN initiative.

Professor Natasha Lannin, who leads the Brain Recovery and Rehabilitation Research Group in the Department of Neuroscience, is an investigator on a project funded by the RCRDUN Initiative. This $3.48M five year project is led by Professor David Berlowitz who is Chair of Physiotherapy (Austin Health) for the University of Melbourne.

Together the investigator team will conduct a trial measuring the effectiveness of non-invasive ventilation during sleep in people who suffer from Motor neurone disease (MND) then develop a comprehensive implementation package to move findings into clinical care.

MRFF funding success for discovering new drugs for epilepsy using personalised medicine

CIA Professor Patrick Kwan (left)  and  CIB Dr Ben Rollo (right),
both in the Central Clinical School’s Department of Neuroscience. 
The team includes CIC Dr Chris Langmead (Drug Discovery Biology, MIPS), 
CID Dr Katie Ayers (MCRI) and CIE Dr Alexander Harris (UniMelb)

Congratulations to Professor Patrick Kwan and colleagues, who have been awarded a MRFF Stem Cell Therapies Mission grant for $556,460. This grant was part of a suite to support research on treatments for incurable disease announced by the Commonwealth Minister for Health Greg Hunt on 20 June.

Epilepsy is a severe neurological disease which affects over 70 million people globally. Despite a concerted effort to identify new anti-seizure medications (ASMs) over the last 25 years, epilepsy remains uncontrolled in 30% of individuals, a condition known as drug-resistant epilepsy. Therefore, there exists an urgent unmet clinical need to identify new effective drugs to treat epilepsy.

16-22 June 2020 Central Clinical School recent publications

L-R: A/Prof Jane Muir and Prof Peter Gibson have
co-authored a review paper with Dr Emma Halmos,
who completed her PhD under their supervision.
The paper is on FODMAPS, prebiotics and gut health.

Recent publications as notified by PubMed during the week 16-22 June 2020 from Central Clinical School affiliated researchers in the following departments. This is not a comprehensive list:

• Australian Centre for Blood Diseases
• Diabetes
• Gastroenterology 
• Immunology and Pathology
• Medicine - Peninsula
• Melbourne Sexual Health Centre
• Neuroscience
• National Trauma Research Institute